Contact Us
Contact Us
Contact Us

Race Oncology 2019 Annual General Meeting Presentation

• Overview of Race Oncology’s new “5 path” strategy for the development of Bisantrene. 0.00 – 10.00

• Introduction & welcome | Mr Peter Molloy CEO/MD 10.00 – 39.01

• Race’s 5 Path strategy | Dr Daniel Tillett CSO 39.01 – 45.23

• Conclusion | Mr Peter Molloy CEO/MD

Videography and editing by Sirius Productions

© 2019 Race Oncology. Website By Multiplier